This unique dual formulation provides the potential benefit for smooth transition from short-term intravenous to long-term oral antiplatelet therapy. It has a plasma half-life of approximately 12 ...

In updated American recommendations for the management of acute coronary syndrome (ACS), bleeding reduction strategies on antiplatelet therapy are embraced, as are non-statin lipid-lowering ...

No writing assistance was utilized in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of ...